Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41581-020-00379-y http://scihub22266oqcxt.onion/10.1038/s41581-020-00379-y 33230249!7682124!33230249     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33230249&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Nat+Rev+Nephrol 2021 ; 17 (4): 225-226 Nephropedia Template TP {{tp|p=33230249|t=2021. The seroprevalence of SARS-CoV-2 in patients on haemodialysis |pdf=|usr=}}{{33230249}} gab.com Text The seroprevalence of SARS-CoV-2 in patients on haemodialysis JO: Nat Rev Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=33230249 #FOAvip A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution. Twit Text FOAVip The seroprevalence of SARS-CoV-2 in patients on haemodialysis ????Nat Rev Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=33230249 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33230249 #FOAvip English Wikipedia <ref>{{Cite pmid|33230249}}</ref> The seroprevalence of SARS-CoV-2 in patients on haemodialysis #MMPMID33230249 Mahalingasivam V; Tomlinson L Nat Rev Nephrol 2021[Apr]; 17 (4): 225-226 PMID33230249show ga A new study reports the seroprevalence of SARS-CoV-2 antibodies among a cross-section of patients on haemodialysis and uses these data to estimate seroprevalence in the general US population. Although this study demonstrates the potential of monitoring infectious disease prevalence in dialysis populations, the findings should be interpreted with caution. |*COVID-19[MESH] |*SARS-CoV-2[MESH] |Cross-Sectional Studies[MESH] |Humans[MESH] |Prevalence[MESH] |Renal Dialysis/adverse effects[MESH] |Seroepidemiologic Studies[MESH]The seroprevalence of SARS-CoV-2 in patients on haemodialysis (epmc).pdf DeepDyve Pubget Overpricing